Iowa Code 139A.26 – Meningococcal disease vaccination information for postsecondary students
Current as of: 2024 | Check for updates
|
Other versions
1. Each institution of higher education that has an on-campus residence hall or dormitory shall provide vaccination information on meningococcal disease to each student enrolled in the institution. The vaccination information shall be contained on student health forms provided to each student by the institution, which forms shall include space for the student to indicate whether or not the student has received the vaccination against meningococcal disease. The vaccination information about meningococcal disease shall include any recommendations issued by the national centers for disease control and prevention regarding the disease. Vaccination information obtained under this section that is in the possession of an institution of higher education pursuant to this section shall not be considered a public record. Data obtained under this section shall be submitted annually to the department in a manner prescribed by the department and such that no individual person can be identified.
Terms Used In Iowa Code 139A.26
- Department: means the department of inspections, appeals, and licensing. See Iowa Code 154A.1
- Person: means a natural person. See Iowa Code 154A.1
- year: means twelve consecutive months. See Iowa Code 4.1
2. This section shall not be construed to require any institution of higher education to provide the vaccination against meningococcal disease to students.
3. This section shall not apply if the national centers for disease control and prevention no longer recommend the meningococcal disease vaccine.
4. This section does not create a private right of action.
5. The department shall adopt rules for administration of this section. The department shall review the requirements of this section at least every five years, and shall submit its recommendations for modification to, or continuation of, this section based upon new information about the disease or vaccination against the disease in a report that shall be submitted to the general assembly no later than January 15, 2010, with subsequent reports developed and submitted by January 15 at least every fifth year thereafter.